VSM Wealth Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$906K Buy
755
+712
+1,656% +$727K 0.24% 40
2026
Q1
$14.8K Sell
43
-796
-95% -$807K ﹤0.01% 325
2025
Q4
$902K Sell
839
-100
-11% -$95.6K 0.27% 39
2025
Q3
$716K Sell
939
-800
-46% -$595K 0.22% 44
2025
Q2
$1.36M Sell
1,739
-18
-1% -$14K 0.45% 30
2025
Q1
$1.45M Hold
1,757
0.52% 30
2024
Q4
$1.36M Buy
+1,757
New +$1.45M 0.48% 32

Other funds holding LLY

VSM Wealth Advisory's LLY Position: Q2 2026 in Review

VSM Wealth Advisory increased its Eli Lilly (LLY) stake by 1,656% in Q2 2026, buying an estimated $727K and bringing the position to 755 shares worth $906K. The position accounts for 0.24% of the portfolio, ranked #40.

VSM Wealth Advisory first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.45M in Q1 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • VSM Wealth Advisory held 755 shares of Eli Lilly worth $906K as of Q2 2026.
  • VSM Wealth Advisory bought 712 Eli Lilly shares in Q2 2026, an estimated $727K.
  • Eli Lilly made up 0.24% of VSM Wealth Advisory's portfolio in Q2 2026, its #40 holding.
  • VSM Wealth Advisory first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • VSM Wealth Advisory's Eli Lilly position peaked at $1.45M in Q1 2025.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on VSM Wealth Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.